Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: -0.212x

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) has a cash flow conversion efficiency ratio of -0.212x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-19.96 Million ≈ $-2.92 Million USD) by net assets (CN¥94.30 Million ≈ $13.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (1998–2025)

Cash flow conversion efficiency of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd from 1998 to 2025. This chart illustrates how Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 600671 share price today for real-time trading data and today's change.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Cash Flow Conversion Ratio Explained

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd ranked by their cash flow conversion efficiency. Also see 600671 company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Pollard Banknote Limited TO:PBL	0.007x
Suzhou Fushilai Pharmaceutical Co. Ltd. SHE:301258	N/A
Guangdong Real-Design Intelligent Technology Co. Ltd. SHE:301135	-0.019x
Ningbo Color Master Batch Co. Ltd. SHE:301019	0.030x
Hubei Guochuang Hi-tech Material Co Ltd SHE:002377	-0.092x
Ercros MC:ECR	0.137x
Build-A-Bear Workshop Inc NYSE:BBW	0.031x
AnHui Annada Titanium Industry Co Ltd SHE:002136	0.022x

Annual Cash Flow Conversion Efficiency for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd from 1998 to 2025. Review 600671 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥93.99 Million ≈ $13.75 Million	CN¥11.79 Million ≈ $1.73 Million	0.125x	+129.08%
2024-12-31	CN¥85.02 Million ≈ $12.44 Million	CN¥-36.67 Million ≈ $-5.37 Million	-0.431x	-18.14%
2023-12-31	CN¥55.95 Million ≈ $8.19 Million	CN¥-20.43 Million ≈ $-2.99 Million	-0.365x	+91.56%
2022-12-31	CN¥4.48 Million ≈ $655.53K	CN¥-19.37 Million ≈ $-2.83 Million	-4.324x	-956.52%
2021-12-31	CN¥64.56 Million ≈ $9.45 Million	CN¥-26.42 Million ≈ $-3.87 Million	-0.409x	-354.96%
2020-12-31	CN¥93.33 Million ≈ $13.66 Million	CN¥-8.40 Million ≈ $-1.23 Million	-0.090x	-107.44%
2019-12-31	CN¥133.33 Million ≈ $19.51 Million	CN¥161.13 Million ≈ $23.58 Million	1.209x	+39.51%
2018-12-31	CN¥81.62 Million ≈ $11.94 Million	CN¥70.71 Million ≈ $10.35 Million	0.866x	+240.09%
2017-12-31	CN¥96.27 Million ≈ $14.09 Million	CN¥24.52 Million ≈ $3.59 Million	0.255x	+949.12%
2016-12-31	CN¥66.18 Million ≈ $9.68 Million	CN¥1.61 Million ≈ $235.13K	0.024x	+203.93%
2015-12-31	CN¥62.76 Million ≈ $9.18 Million	CN¥-1.47 Million ≈ $-214.52K	-0.023x	-404.59%
2014-12-31	CN¥85.25 Million ≈ $12.47 Million	CN¥653.79K ≈ $95.67K	0.008x	-94.10%
2013-12-31	CN¥95.26 Million ≈ $13.94 Million	CN¥12.37 Million ≈ $1.81 Million	0.130x	+160.78%
2012-12-31	CN¥92.76 Million ≈ $13.57 Million	CN¥-19.82 Million ≈ $-2.90 Million	-0.214x	-501.81%
2011-12-31	CN¥182.84 Million ≈ $26.75 Million	CN¥-6.49 Million ≈ $-950.05K	-0.036x	+56.56%
2010-12-31	CN¥154.14 Million ≈ $22.55 Million	CN¥-12.60 Million ≈ $-1.84 Million	-0.082x	-302.37%
2009-12-31	CN¥187.74 Million ≈ $27.47 Million	CN¥7.58 Million ≈ $1.11 Million	0.040x	-54.19%
2008-12-31	CN¥240.30 Million ≈ $35.16 Million	CN¥21.19 Million ≈ $3.10 Million	0.088x	-47.51%
2007-12-31	CN¥282.93 Million ≈ $41.40 Million	CN¥47.53 Million ≈ $6.96 Million	0.168x	-28.28%
2006-12-31	CN¥236.44 Million ≈ $34.60 Million	CN¥55.39 Million ≈ $8.10 Million	0.234x	+561.08%
2005-12-31	CN¥239.39 Million ≈ $35.03 Million	CN¥8.48 Million ≈ $1.24 Million	0.035x	+560.32%
2004-12-31	CN¥252.36 Million ≈ $36.93 Million	CN¥1.35 Million ≈ $198.17K	0.005x	+103.17%
2003-12-31	CN¥242.64 Million ≈ $35.51 Million	CN¥-41.13 Million ≈ $-6.02 Million	-0.170x	-296.91%
2002-12-31	CN¥253.20 Million ≈ $37.05 Million	CN¥21.80 Million ≈ $3.19 Million	0.086x	+105.99%
2001-12-31	CN¥251.63 Million ≈ $36.82 Million	CN¥10.52 Million ≈ $1.54 Million	0.042x	+208.63%
2000-12-31	CN¥251.29 Million ≈ $36.77 Million	CN¥-9.67 Million ≈ $-1.41 Million	-0.038x	-119.13%
1999-12-31	CN¥244.10 Million ≈ $35.72 Million	CN¥49.09 Million ≈ $7.18 Million	0.201x	+1911.55%
1998-12-31	CN¥235.71 Million ≈ $34.49 Million	CN¥2.36 Million ≈ $344.84K	0.010x	--

About Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd

SHG:600671 China Drug Manufacturers - General

Market Cap

$319.16 Million

CN¥2.18 Billion CNY

Market Cap Rank

#14200 Global

#4221 in China

Share Price

CN¥17.91

Change (1 day)

+0.62%

52-Week Range

CN¥15.94 - CN¥23.90

All Time High

CN¥37.82